Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer
- PMID: 19484788
- DOI: 10.1002/cncr.24393
Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer
Comment on
-
Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival.Cancer. 2009 Aug 1;115(15):3437-45. doi: 10.1002/cncr.24395. Cancer. 2009. PMID: 19536889 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
